Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Sales (2016 - 2025)

Amphastar Pharmaceuticals has reported Return on Sales over the past 13 years, most recently at 0.32% for Q4 2025.

  • Quarterly results put Return on Sales at 0.32% for Q4 2025, up 9.0% from a year ago — trailing twelve months through Dec 2025 was 0.18% (down 4.0% YoY), and the annual figure for FY2025 was 0.18%, down 4.0%.
  • Return on Sales for Q4 2025 was 0.32% at Amphastar Pharmaceuticals, up from 0.09% in the prior quarter.
  • Over the last five years, Return on Sales for AMPH hit a ceiling of 0.32% in Q4 2025 and a floor of 0.82% in Q4 2023.
  • Median Return on Sales over the past 5 years was 0.19% (2023), compared with a mean of 0.09%.
  • Biggest five-year swings in Return on Sales: plummeted -89bps in 2022 and later soared 105bps in 2024.
  • Amphastar Pharmaceuticals' Return on Sales stood at 0.2% in 2021, then plummeted by -453bps to 0.69% in 2022, then dropped by -18bps to 0.82% in 2023, then surged by 129bps to 0.23% in 2024, then skyrocketed by 37bps to 0.32% in 2025.
  • The last three reported values for Return on Sales were 0.32% (Q4 2025), 0.09% (Q3 2025), and 0.18% (Q2 2025) per Business Quant data.